Thomas Hope
Thomas Hope
This is a prospective single arm single center Phase III study evaluating the ability of 18F-fluorocholine to detect the location of parathyroid adenomas.
Hyperparathyroidism, Primary
18F-Fluorocholine
Positron emission tomography (PET)
PHASE3
PRIMARY OBJECTIVE: I. To investigate the performance (accuracy) of 18F-fluorocholine PET in the detection of hyperfunctioning parathyroid glands in surgical patients with biochemically proven primary hyperparathyroidism. OUTLINE: Participants will receive a single dose of 18F-Fluorocholine at the time the participant undergoes a single imaging study using 18F-fluorocholine. Study related procedures will end after the study visit. Participants who undergo subsequent parathyroidectomy, will have the results reviewed and compared to the results from the imaging study
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 140 participants |
Masking : | NONE |
Primary Purpose : | DIAGNOSTIC |
Official Title : | 18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas |
Actual Study Start Date : | 2021-06-30 |
Estimated Primary Completion Date : | 2026-06-30 |
Estimated Study Completion Date : | 2027-06-30 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 13 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
University of California, San Francisco
San Francisco, California, United States, 94107